Access cutting-edge advanced cancer treatment through this clinical trial at a research site in Fullerton. Study-provided care at no cost to qualified participants.
Access advanced cancer specialists in Fullerton at no cost
This study follows strict safety protocols and ethical guidelines
All study-related advanced cancer treatment provided free
The purpose of this study is to evaluate the long-term safety and efficacy of pembrolizumab (MK-3475) in participants from previous Merck pembrolizumab-based parent studies who transition into this extension study. This study will consist of three phases: 1) First Course Phase, 2) Survival Follow-up Phase or 3) Second Course Phase. Each participant will transition to this extension study in one of the following three phases, depending on the study phase they were in at the completion of the par
Sponsor: Merck Sharp & Dohme LLC
Check if you qualify for this advanced cancer clinical trial in Fullerton, CA
If you're searching for advanced cancer treatment options in Fullerton, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fullerton research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.